Naiem Hussain - Feb 2, 2024 Form 3 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role
Chief Financial Officer
Signature
/s/ Naiem Hussain
Stock symbol
ADN
Transactions as of
Feb 2, 2024
Transactions value $
$0
Form type
3
Date filed
2/12/2024, 03:52 PM
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADN Common Stock 85K Feb 2, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADN Employee Stock Options (right to buy) Feb 2, 2024 Common Stock 40K $2.74 Direct F2, F3
holding ADN Employee Stock Options (right to buy) Feb 2, 2024 Common Stock 45K $2.94 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 45,000 restricted stock units ("RSUs") granted July 12, 2022, and 40,000 RSUs granted March 18, 2022, each representing a contingent right to receive common stock. Such RSUs were granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan"). RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. These RSUs vest 25% on each anniversary of their grant date over four years.
F2 Employee stock options (right to buy) ("Options") granted pursuant to the Plan.
F3 Options vest 25% per year over four years on each anniversary of the grant date and will be fully vested as of March 18, 2025.
F4 Options vest 25% per year over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026.